C

Cerulean Pharma, Inc

12 employees

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics
Nanotechnology

Date founded

2006

Funding rounds raised

Total raised

$26M

from 24 investors over 24 rounds

C

Cerulean Pharma, Inc raised $26M on January 9, 2015

Investors: Hercules Capital, Inc.

C

Cerulean Pharma, Inc raised $13M on December 14, 2012

Investors: Venrock, Lux Capital, Lilly Ventures, Polaris Partners and Bessemer Venture Partners

C

Cerulean Pharma, Inc raised $15M on December 15, 2011

Investors: Bessemer Venture Partners, Lux Capital, Polaris Partners, Lilly Ventures and Venrock

C

Cerulean Pharma, Inc raised $24M on November 15, 2010

Investors: Bessemer Venture Partners, Venrock, Polaris Partners, Lux Capital and Lilly Ventures

C

Cerulean Pharma, Inc raised $10M on July 28, 2009

Investors: Venrock, Polaris Partners, Bessemer Venture Partners and Lux Capital

C

Cerulean Pharma, Inc raised $8.1M on January 3, 2008

Investors: Lux Capital, Polaris Partners, Venrock and Bessemer Venture Partners

FAQ